Form 4: Allstate exec exercises options, sells 400 shares

Allstate’s President, Enterprise Solutions, exercised 400 options at $62.32 and sold the shares at a $215.215 weighted average under a pre-set Rule 10b5-1 plan.

Summary

• On 11/17/2025, Suren Gupta (President, Enterprise Solutions) exercised 400 employee stock options at $62.32 and sold 400 common shares at a weighted average price of $215.215 (actual sale range: $215.20–$215.25).
• Transactions were executed pursuant to a Rule 10b5-1(c) trading plan adopted on 06/09/2025.
• Direct beneficial ownership after the transactions: 100,646 common shares.
• Indirect holdings: 1,329 shares via a 401(k) plan and 7 shares via VVG Holdings LLC.
• Following the transaction, 46,600 employee stock options (right to buy) remain outstanding for the reported series with a $62.32 exercise price and 02/11/2026 expiration.
• Form signed by attorney-in-fact on 11/19/2025.

Sentiment

Score: 5

Explanation: Neutral; a small, pre-planned insider sale alongside an option exercise with substantial remaining ownership and options.

Positives

• Pre-arranged Rule 10b5-1 plan reduces information-asymmetry concerns and signaling risk.
• Small sale size (400 shares) relative to total direct holdings; Gupta retains 100,646 directly held shares.
• Execution price materially above exercise price (sale weighted average $215.215 vs. $62.32 exercise).
• Significant remaining option alignment (46,600 options outstanding in the reported series).

Negatives

• An insider sale can be perceived negatively by some investors despite its small size.
• Direct share count decreased by 400 shares.

Future Outlook

No forward-looking statements or company guidance are provided; this reflects a routine insider transaction under a pre-established Rule 10b5-1 plan.

Management Comments

• Transactions were effected pursuant to a Rule 10b5-1(c) trading plan adopted on 06/09/2025.
• The weighted average sale price was $215.215; actual sales occurred between $215.20 and $215.25, and full price-by-lot details are available upon request.

Industry Context

Pre-arranged insider trades under Rule 10b5-1 plans are routine across large U.S. insurers and other S&P 500 companies, especially following enhanced SEC requirements; single-lot sales of this size are typically not viewed as indicative of business performance.

Comparison to Industry Standards

• Insider activity scale: A 400-share sale is immaterial relative to insider transactions often seen at peers like Progressive (PGR), Travelers (TRV), and Hartford (HIG), where trades can involve thousands to tens of thousands of shares.
• Use of Rule 10b5-1 plans: Consistent with industry best practices adopted post-SEC rule updates, aligning with common governance standards among U.S. insurers.
• Signal interpretation: Similar small, plan-driven transactions at peers are generally treated as neutral with limited signaling value for operating performance.

Stakeholder Impact

• Minimal expected market impact due to small transaction size and 10b5-1 plan structure.
• Alignment maintained with shareholders given substantial remaining direct ownership (100,646 shares) and outstanding options.

Next Steps

• Additional trades may occur under the existing Rule 10b5-1 plan adopted on 06/09/2025.
• Reported option series expires on 02/11/2026.

Key Dates

Keywords

Allstate, ALL, Form 4, insider transaction, Rule 10b5-1, employee stock option, beneficial ownership, stock sale, Suren Gupta, 401(k) plan